Trials / Recruiting
RecruitingNCT05112328
The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding
The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding: Prospective Randomized Controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Determine the effect of high-dose pancreatic enzyme supplementation on nutritional indicators and clinical course in critically ill patients undergoing enteral nutrition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Exocrine Pancreatic Enzyme | Pancreatic enzyme supplementation for critically ill patients on enteral nutrition |
| DRUG | Placebo | Placebo of Pancreatic enzyme for critically ill patients on enteral nutrition |
Timeline
- Start date
- 2021-07-07
- Primary completion
- 2026-07-31
- Completion
- 2026-07-31
- First posted
- 2021-11-08
- Last updated
- 2021-11-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05112328. Inclusion in this directory is not an endorsement.